Joth Jacobson - Concepedia

Author

Joth Jacobson

Cancer Research And Biostatistics

Also Known As

J JACOBSON, J. L. Jacobson, Joth Jacobson, Joth L. Jacobson

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Cancer Research And Biostatistics SWOG Cancer Research Network University of Arkansas for Medical Sciences Fred Hutch Cancer Center Cleveland Clinic

About

Joth Jacobson is an author at Cancer Research And Biostatistics specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	778
2	Health Sciences	3	3	245
3	Engineering	1	1	21
4	Public Health	1	1	40
5	African American Studies	1	1	40

Joth Jacobson

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma Bart Barlogie, Sundar Jagannath, David H. Vesole, Blood	1997	553
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation Maurizio Zangari, Bart Barlogie, Elias Anaissie, British Journal of Haematology	2004	221
Results of the U.S. Multicenter Pivotal Study of the HELEX Septal Occluder for Percutaneous Closure of Secundum Atrial Septal Defects Thomas K. Jones, Larry Latson, Evan M. Zahn, Journal of the American College of Cardiology Helex Septal OccluderSurgeryMedicinePercutaneous ClosureAnesthesiology	2007	178
DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma Choon‐Kee Lee, Bart Barlogie, Nikhil C. Munshi, Journal of Clinical Oncology	2003	175
Prognostic impact of cytogenetic and interphase fluorescence <i>in situ</i> hybridization‐defined chromosome 13 deletion in multiple myeloma: early results of total therapy II John D. Shaughnessy, Erming Tian, Jeffrey R. Sawyer, British Journal of Haematology	2002	150
Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003) Madhav V. Dhodapkar, Joth Jacobson, Morie A. Gertz, Blood	2001	147
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression John D. Shaughnessy, Joth Jacobson, Jeff Sawyer, Blood	2003	132
Magnitude of Response With Myeloma Frontline Therapy Does Not Predict Outcome: Importance of Time to Progression in Southwest Oncology Group Chemotherapy Trials Brian G.M. Durie, Joth Jacobson, Bart Barlogie, Journal of Clinical Oncology	2004	132
A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience Joth Jacobson, Mohamad A. Hussein, Bart Barlogie, British Journal of Haematology Cancer ManagementSouthwest Oncology GroupPrognosisPathologyHematological Malignancy	2003	117
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival Kaida Wu, Lisa Orme, John D. Shaughnessy, Blood	2003	113

Page 1